Phibro Animal Health CorpPAHC

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$33.93
Market cap
$1.4B
P/E
14.0x
Revenue (TTM)
$1.5B
Net income
$99.7M
Dividend yield
1.41%
1-year total return
-9.7%
Net margin
6.6%
Revenue growth
17.1%
Debt / equity
1.61x

What Phibro Animal Health Corp does.

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We market approximately 790 product lines in approximately 90 countries to approximately 4,800 customers. We develop, manufacture and market a broad range of products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, cattle and swine producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.

● Animal health products such as antibacterials, anticoccidials, nutritional specialty products, and vaccines and vaccine adjuvants that help improve the animal’s health and therefore improve performance, food safety and animal welfare. Our Animal Health segment also includes antibacterials and other processing aids used in the ethanol fermentation industry.

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$833.4M$942.3M$977.9M$1.0B$1.3B$1.5B
Net income$54.4M$49.2M$32.6M$2.4M$48.3M$99.7M
Free cash flow$19.0M-$5.4M-$38.5M$46.4M$41.8M$9.9M

More on PAHC.

Figures from Phibro Animal Health Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.